Drug company marketing ISN’T the cause of the ADHD epidemic


ad_monsterThis past Sunday, the New York Times ran a lengthy feature article that created quite the stir in our professional community. The article, titled The Selling of Attention Deficit Disorder, spelled out in great detail the marketing practices the pharmaceutical industry has employed over the last twenty years in promoting the use of medications in kids and adults primarily indicated for ADHD, with a focus on the strategies of the company (Shire) that has been the market leader in ADHD for the past ten years.

There’s a study coming out in the January issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) that reinforces the extent to which ADHD diagnosis is truly reaching epidemic proportions. Here’s a portion of the abstract


In 2011, 11% of children/adolescents aged 4 to 17 years had ever received an ADHD diagnosis (6.4 million children). Among those…

View original post 1,358 more words


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s